These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5996746)

  • 1. [Studies on insulin loading in healthy subjects and liver patients].
    Waldhäusl W; Wewalka F
    Wien Klin Wochenschr; 1966 Oct; 78(43):734-6. PubMed ID: 5996746
    [No Abstract]   [Full Text] [Related]  

  • 2. [Distribution of biliary lipids in healthy subjects, in liver cirrhosis, fatty liver and in cholecystitis].
    Erb W; Kautzsch S
    Z Gastroenterol; 1971; 9(6):447-60. PubMed ID: 5164737
    [No Abstract]   [Full Text] [Related]  

  • 3. [Glycoregulation and liver diseases].
    Guillon J; Charbonnel B; Le Bodic L; Chupin M; Ozanne P; Veyrac MJ
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():181-95. PubMed ID: 6995669
    [No Abstract]   [Full Text] [Related]  

  • 4. [Microluminescence, ultrastructure, porphyrin metabolism in liver diseases].
    Róth I; Várkonyi S; Goreczky L; Breckner M; Szücs O; Balázs M
    Z Gesamte Inn Med; 1971 May; 26(10):323-7. PubMed ID: 5131400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood glucose curves following glucagon loading in children with chronic impairment of liver function and in the acute phase of infectious hepatitis].
    Jablońska A
    Pol Tyg Lek; 1973 Aug; 28(33):1257-9. PubMed ID: 4742293
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of the liver in the regulation of glucose metabolism in diabetes and chronic liver disease].
    Cotrozzi G; Casini Raggi V; Relli P; Buzzelli G
    Ann Ital Med Int; 1997; 12(2):84-91. PubMed ID: 9333317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis.
    Kaser S; Moschen A; Kaser A; Ludwiczek O; Ebenbichler CF; Vogel W; Jaschke W; Patsch JR; Tilg H
    J Intern Med; 2005 Sep; 258(3):274-80. PubMed ID: 16115302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperinsulinaemia and impaired glucose tolerance in chronic inflammatory liver disease (author's disease)].
    Oehler G; Bleyl H; Knecht M; Matthes K
    Z Gastroenterol; 1981 Jan; 19(1):26-32. PubMed ID: 7222867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of hepatic coproporphyria with various interesting anomalies].
    Nozawa T; Matsuzaki S; Sawano S; Shizume K; Nakayama T
    Naika; 1972; 29(2):378-84. PubMed ID: 5015110
    [No Abstract]   [Full Text] [Related]  

  • 10. [The behavior of lipid metabolism parameters in liver cirrhosis and fatty liver during glucose load].
    Rogos R; Meisel B; Erler K
    Z Gesamte Inn Med; 1982 May; 37(9):271-5. PubMed ID: 7102013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on vitamin B12 resorption in chronic liver diseases].
    Konrad H; Teichmann W; Kiencke H; Bielka B; Claus R
    Dtsch Z Verdau Stoffwechselkr; 1973; 33(4):179-83. PubMed ID: 4792418
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.
    Tsochatzis EA; Manolakopoulos S; Papatheodoridis GV; Archimandritis AJ
    Scand J Gastroenterol; 2009; 44(1):6-14. PubMed ID: 18661429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activity of granulocytic alkaline phosphatase in parenchymal liver diseases of varied etiology].
    Wichrzycka E; Pawelski S
    Pol Tyg Lek; 1966 Jan; 21(3):86-8. PubMed ID: 5907711
    [No Abstract]   [Full Text] [Related]  

  • 14. [Liver diseases and abnormal sugar metabolism].
    Ohnishi K; Okuda K
    Nihon Rinsho; 1982 Feb; 40(2):415-21. PubMed ID: 7045460
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavior of lipid classes and fatty acids in different stages of alcoholic liver disease].
    Marzo A; Ghirardi P
    Recenti Prog Med; 1971 Nov; 51(5):409-19. PubMed ID: 5172395
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aminophenazone half life in patients with chronic liver parenchyma disorders].
    Ackermann E; Renger F; Dökert B; Walther M
    Z Gesamte Inn Med; 1972 Oct; 27(19):849-53. PubMed ID: 4647370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of the isotope method for studying albumin metabolism in patients with chronic liver diseases].
    Vinogradov VA; Baranenkov AI
    Ter Arkh; 1974; 46(3):118-23. PubMed ID: 4828489
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin resistance in liver disease and portal hypertension.
    Petrides AS; Strohmeyer G; DeFronzo RA
    Prog Liver Dis; 1992; 10():311-28. PubMed ID: 1296234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iron metabolism and enteral iron absorption in liver diseases].
    Rommel K; Gladtke E; Mähr G; Grimmel K; Burkhardt H
    Schweiz Med Wochenschr; 1968 Nov; 98(47):1854-9. PubMed ID: 5704710
    [No Abstract]   [Full Text] [Related]  

  • 20. Carbohydrate-induced thermogenesis in liver cirrhosis: glucose vs. fructose.
    Martines D; Martines V; Pasini M; Cocco G; Lora L; Varnier M; Venier GB; Sammartano G; Naccarato R
    Nutrition; 1994; 10(6):521-6. PubMed ID: 7703598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.